ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR)

CUSIP: N71542109

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Ordinary Shares, nominal value Euro 0.04 per share
Shares outstanding
105,371,575
Total 13F shares
39,831,678
Share change
+1,345,133
Total reported value
$333,392,000
Put/Call ratio
115%
Price per share
$8.37
Number of holders
65
Value change
+$12,212,303
Number of buys
38
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP N71542109?
CUSIP N71542109 identifies PRQR - ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) as of Q3 2021

As of 30 Sep 2021, ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) was held by 65 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,831,678 shares. The largest 10 holders included RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., GOLDMAN SACHS GROUP INC, DRIEHAUS CAPITAL MANAGEMENT LLC, JENNISON ASSOCIATES LLC, Opaleye Management Inc., FIL Ltd, and GILDER GAGNON HOWE & CO LLC. This page lists 65 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.